Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kytopure

PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Provider of drug delivery and medical products. The company develop and market a series of clinically significant therapies and products based on its N,O- carboxymethylchitosan chitosan (NOCC) derived technology and its sulfated derivative s-NOCC.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Therapeutic Devices
Other Industries
Drug Delivery
Other Healthcare Services
Primary Office
  • 1 Research Drive
  • Dartmouth, Nova Scotia B2Y 4M9
  • Canada

+1 (902) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Kytopure’s full profile, request a free trial.

Kytopure Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Kytopure Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Innovacorp Venture Capital Minority 000 0000 000000 0